|
FY2021
12 months to Dec 31, 2021
|
FY2020
4 months to Dec 31, 2020
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Change in fair value of warrant liabilities | ||
| Loss on initial issuance of Private Placement Warrants | ||
| Interest earned on marketable securities held in Trust Account | ||
| Transaction costs allocated to warrant liabilities | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Accrued expenses | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash in Trust Account | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from issuance of Class B common stock to Initial Stockholders | ||
| Proceeds from sale of Units, net of underwriting discounts paid | ||
| Proceeds from sale of Private Placement Warrants | ||
| Proceeds from promissory note - related party | ||
| Repayment of promissory note - related party | ||
| Payment of offering costs | ||
| Net cash provided by financing activities | ||
| Net Change in Cash | ||
| Cash - Beginning of period | ||
| Cash - End of period | ||
| Non-Cash investing and financing activities: | ||
| Deferred offering costs included in accrued offering costs | ||
| Offering costs included in accrued offering costs | ||
| Accretion of Class A common stock subject to possible redemption | ||
| Deferred underwriting fee payable |
Loading...
